Shanghai Labway Clinical Laboratory Co., Ltd (SHE:301060)
China flag China · Delayed Price · Currency is CNY
10.97
+0.27 (2.52%)
Sep 1, 2026, 3:04 PM CST

SHE:301060 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
761.42759.5828.95861.2665.81351.96
Trading Asset Securities
-----420.93
Cash & Short-Term Investments
761.42759.5828.95861.2665.81772.89
Cash Growth
7.60%-8.38%-3.74%29.35%-13.85%45.09%
Accounts Receivable
605.82686.13808.631,0332,249819.61
Other Receivables
5.144.9214.546.0811.837.89
Receivables
610.96691.05823.171,0402,261827.5
Inventory
246.19269.81306.09367.71401.52139.44
Prepaid Expenses
---0.118.45-
Other Current Assets
28.1731.4540.4357.9751.5627.23
Total Current Assets
1,6471,7521,9992,3273,3891,767
Property, Plant & Equipment
404.48434.04482.58509.74220.96241.11
Long-Term Investments
0.840.981.7614.0616.74-
Goodwill
7.667.667.6615.2417.6430.09
Other Intangible Assets
21.3323.6724.4526.513.0614.81
Long-Term Accounts Receivable
-0.960.25---
Long-Term Deferred Tax Assets
49.3959.6673.8248.9530.1313.39
Long-Term Deferred Charges
14.6512.6530.0437.1749.632.05
Other Long-Term Assets
2.060.774.128.6710.166.97
Total Assets
2,1472,2922,6232,9873,7472,105

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
318.8402.62388.99502.36858.69253.03
Accrued Expenses
16.7150.2761.9850.07253.6490.24
Short-Term Debt
-25.0195.11214.59182.162
Current Portion of Long-Term Debt
16.3328.9915.1415.15--
Current Portion of Leases
-8.0512.0810.7716.8113.67
Current Income Taxes Payable
6.643.6612.549.7351.7628.91
Current Unearned Revenue
29.327.2415.126.628.739.28
Other Current Liabilities
19.285.3214.6413.5522.0315.85
Total Current Liabilities
407.07531.18615.59822.831,414412.98
Long-Term Debt
92104133.7145.77--
Long-Term Leases
5.95.3818.2721.0745.6250.03
Long-Term Unearned Revenue
4.946.7110.4211.9414.682.66
Other Long-Term Liabilities
-0.1225.025.09--
Total Liabilities
509.92647.398031,0071,474465.67

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
400.52400.52400.52400.52400.52400.52
Additional Paid-In Capital
555.57554.76553.96553.96553.96552.8
Retained Earnings
618.52616.86727.31836.751,109611.62
Treasury Stock
-23.01-23.01-23.01-10.26--
Comprehensive Income & Other
-0.65-0.65-0.65-0.65--
Total Common Equity
1,5511,5481,6581,7802,0631,565
Minority Interest
86.2996.35162.21199.85209.4974.88
Shareholders' Equity
1,6371,6451,8201,9802,2731,640
Total Liabilities & Equity
2,1472,2922,6232,9873,7472,105

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
114.23171.44274.29407.35244.5965.7
Net Cash (Debt)
647.2588.06554.66453.85421.22707.19
Net Cash Growth
33.94%6.02%22.21%7.75%-40.44%32.75%
Net Cash Per Share
2.201.531.371.121.052.01
Filing Date Shares Outstanding
384.77398.52398.52399.77400.52400.52
Total Common Shares Outstanding
384.77398.52398.52399.77400.52400.52
Working Capital
1,2401,2211,3831,5041,9751,354
Book Value Per Share
4.033.894.164.455.153.91
Tangible Book Value
1,5221,5171,6261,7392,0331,520
Tangible Book Value Per Share
3.963.814.084.355.073.80
Buildings
-334.17337.04333.0258.7728.94
Machinery
-305.35332.87342296.39290.65
Construction In Progress
-10.940.999.52-16.98